New Results
In situ single-cell analysis of canonical breast cancer biomarkers: phenotypic heterogeneity and implications on response to HER2 targeting agents
Garazi Serna, Eloy García, Roberta Fasani, Xavier Guardia, Tomas Pascual, Laia Paré, Fiorella Ruiz-Pace, Antonio Llombart-Cussac, Javier Cortes, Aleix Prat, Paolo Nuciforo
doi: https://doi.org/10.1101/2022.09.21.508826
Garazi Serna
1Molecular oncology group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
Eloy García
2Department of Mathematics and Informatics, University of Barcelona, Barcelona, Spain
Roberta Fasani
1Molecular oncology group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
Xavier Guardia
1Molecular oncology group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
Tomas Pascual
3Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain
4Department of Medical Oncology, Hospital Clínic de Barcelona, Barcelona, Spain
5SOLTI Breast Cancer Research Group, Barcelona, Spain
Laia Paré
6Reveal Genomics, Barcelona, Spain
Fiorella Ruiz-Pace
7Oncology Data Science Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
Antonio Llombart-Cussac
8Department of Medical Oncology, Hospital Arnau de Vilanova, Valencia, Spain; FISABIO, Universidad Católica de Valencia, Spain
Javier Cortes
9International Breast Cancer Center (IBCC), Quirónsalud Group, Barcelona, Spain; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain; Universidad Europea de Madrid, Faculty of Biomedical and Health Sciences, Department of Medicine, Madrid, Spain
Aleix Prat
3Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain
4Department of Medical Oncology, Hospital Clínic de Barcelona, Barcelona, Spain
5SOLTI Breast Cancer Research Group, Barcelona, Spain
Paolo Nuciforo
1Molecular oncology group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
5SOLTI Breast Cancer Research Group, Barcelona, Spain

Article usage
Posted September 22, 2022.
In situ single-cell analysis of canonical breast cancer biomarkers: phenotypic heterogeneity and implications on response to HER2 targeting agents
Garazi Serna, Eloy García, Roberta Fasani, Xavier Guardia, Tomas Pascual, Laia Paré, Fiorella Ruiz-Pace, Antonio Llombart-Cussac, Javier Cortes, Aleix Prat, Paolo Nuciforo
bioRxiv 2022.09.21.508826; doi: https://doi.org/10.1101/2022.09.21.508826
In situ single-cell analysis of canonical breast cancer biomarkers: phenotypic heterogeneity and implications on response to HER2 targeting agents
Garazi Serna, Eloy García, Roberta Fasani, Xavier Guardia, Tomas Pascual, Laia Paré, Fiorella Ruiz-Pace, Antonio Llombart-Cussac, Javier Cortes, Aleix Prat, Paolo Nuciforo
bioRxiv 2022.09.21.508826; doi: https://doi.org/10.1101/2022.09.21.508826
Subject Area
Subject Areas
- Biochemistry (9550)
- Bioengineering (7071)
- Bioinformatics (24774)
- Biophysics (12566)
- Cancer Biology (9925)
- Cell Biology (14299)
- Clinical Trials (138)
- Developmental Biology (7931)
- Ecology (12077)
- Epidemiology (2067)
- Evolutionary Biology (15957)
- Genetics (10904)
- Genomics (14708)
- Immunology (9847)
- Microbiology (23585)
- Molecular Biology (9456)
- Neuroscience (50699)
- Paleontology (369)
- Pathology (1535)
- Pharmacology and Toxicology (2674)
- Physiology (4001)
- Plant Biology (8642)
- Synthetic Biology (2388)
- Systems Biology (6415)
- Zoology (1345)